NIDA Medications Development Program: Current Research and Collaboration Opportunities

Iván Montoya, Division of Therapeutics and Medical Consequences (DTMC), National Institute on Drug Abuse (NIDA)/National Institute of Health (NIH), USA

Hosts: Félix Carvalho & João Pedro Silva, UCIBIO-FFUP

Amphitheater 10, FFUP
ZOOM link: https://ucibio.pt/l/GuestSeminars

Short Bio:

Dr. Montoya is the Director of the Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA, at the National Institutes of Health (NIH). He has a Medical and Psychiatrist degrees from the University of Antioquia in Colombia, and a Master’s in Public Health from Johns Hopkins University. He was a Fulbright-Humphrey Fellow at Johns Hopkins and Post-doctoral Fellow at the Intramural Research Program of NIDA.  He was the Director of the Practice Research Network of the American Psychiatric Association and Consultant for the Pan American Health Organization, in Washington DC. He joined NIDA’s extramural program in 1999 as Medical Officer of the Clinical Trials Network, became the Deputy Director of DTMC in 2008, and the Director of DTMC in 2024. He has published extensively about treatments (pharmacological and non-pharmacological), and medical consequences of SUDs. He has received multiple awards including the NIH Director’s Award and the Michael Morrison Award from CPDD. He is also Honorary Professor of the University of Valencia (Spain).